There are plenty of cannabis stocks out there but none with the particular positives of Cronos Group... Read More
Raymond James analyst Michael W. Freeman has tempered his expectations on Canadian cannabis name Cro... Read More
Calling it the steadiest name in the cannabis game, Raymond James analyst Rahul Sarugaser reiterated... Read More
The stock kept its “Outperform” rating with investment bankers Raymond James on Tuesday but anal... Read More
Investors looking for a diamond in the rough of Canadian cannabis companies should look no further, ... Read More
Raymond James analyst Rahul Sarugaser is staying solid in his assessment of Cronos Group (Cronos Gro... Read More
The quarterly numbers looks strong for Cronos Group (Cronos Group Stock Quote, Chart, News, Analysts... Read More
After such a promising start to the year it’s safe to say that 2021 has been a bust for Canadian c... Read More
Raymond James analyst Rahul Sarugaser remains confident in Cronos Group (Cronos Group Stock Quote, C... Read More
Raymond James analyst Rahul Sarugaser is confident in Cronos Group (Cronos Group Stock Quote, Chart,... Read More
Patience should soon reward investors in Cronos Group (Cronos Group Stock Quote, Chart, News, Analys... Read More
Cronos Group (Cronos Group Stock Quote, Chart, News, Analysts, Financials TSX:CRON) saw its share pr... Read More
A big earnings miss in its latest quarterly numbers has PI Financial analyst Jason Zandberg staying ... Read More
Expect a cannabis sector sell-off over the next few weeks, says Raymond James analyst Rahul Sarugase... Read More
Start your engines, folks, Canadian cannabis stocks are about to take off. That’s the word from Ra... Read More
The race is on for cannabis companies to take a slice of the US$40-billion biosynthesis pie, says Ra... Read More
The advent of biosynthetic cannabis will be a boost for Canadian licensed producer Cronos Group (Cro... Read More
Despite ongoing murkiness in the US CBD market, stocks like Cronos Group (Cronos Group Stock Quote, ... Read More